Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Read more
FDA Approves Merck’s KEYTRUDA for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer Read more
VITRAC Therapeutics Initiated Global Clinical Development of VIC-1911, licensed from Taiho Pharmaceutical Read more
Biocare Medical and Bethyl Laboratories Announce Strategic Partnership for Antibody Development Read more
Nordic Nanovector’s Betalutin Receives Fast-track Designation from US FDA for Marginal Zone Lymphoma Read more
GSK receives first regulatory approval for Duvroq (daprodustat) in Japan for patients with anaemia due to chronic kidney disease Read more